Elion, a New York-based AI-powered research and intelligence platform for healthcare technology, has raised $9.3 million in a seed funding round.
Investors
The oversubscribed round was led by NEA, with participation from Cedars-Sinai Health Ventures, TMV, Scrub Capital, and Alumni Ventures, alongside existing backers Max Ventures, AlleyCorp, and Floating Point.
New Enterprise Associates, Inc. (NEA) is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. Founded in 1977, NEA has more than $27 billion in assets under management and invests in technology and healthcare companies at all stages in a company’s lifecycle, from seed stage through IPO. The firm's long track record of investing includes more than 280 portfolio company IPOs and more than 470 mergers and acquisitions.
Elion Use of Funds
The company will use the funding to enhance its platform, launch new products, and expand its team across engineering, research, and marketing functions.
About Elion
Elion is a health IT marketplace and research firm that offers an AI-powered research and intelligence platform designed to help healthcare provider organizations make informed technology decisions. By providing a structured, data-rich vendor marketplace covering thousands of healthcare technology companies, Elion enables health systems to evaluate solutions confidently and efficiently. Headquartered in New York, Elion is dedicated to empowering healthcare organizations through technology insights and strategic guidance.
Funding Details
Company: Elion, Inc.
Raised: $9.3M
Round: Seed
Funding Date: August 2025
Lead Investor: NEA
Additional Investors: Cedars-Sinai Health Ventures, TMV, Scrub Capital, Alumni Ventures, Max Ventures, AlleyCorp, Floating Point
Company Website: https://www.elion.health/
Software Category: Healthtech / AI-powered vendor intelligence platform
Source: https://www.businesswire.com/news/home/20250806359832/en/